| scholarly article | Q13442814 |
| P2093 | author name string | Min Xu | |
| Lei Nie | |||
| Seung-Hwan Kim | |||
| Xiao-Hong Sun | |||
| P2860 | cites work | Negative Control of p53 by Sir2α Promotes Cell Survival under Stress | Q24291828 |
| Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms | Q24554353 | ||
| Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain | Q27860534 | ||
| Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase | Q28144544 | ||
| Histone acetyltransferases: function, structure, and catalysis | Q28204852 | ||
| Duration of nuclear NF-kappaB action regulated by reversible acetylation | Q28215080 | ||
| CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription | Q28287446 | ||
| Histone acetylation and transcriptional regulatory mechanisms | Q29547707 | ||
| Acetylation: a regulatory modification to rival phosphorylation? | Q29614886 | ||
| Differentiation of an interleukin 3-dependent precursor B-cell clone into immunoglobulin-producing cells in vitro | Q33582641 | ||
| The "dark side" of chromatin remodeling: repressive effects on transcription | Q33789541 | ||
| The role of STATs in transcriptional control and their impact on cellular function | Q33941346 | ||
| IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled | Q33941375 | ||
| The role of Stat5a and Stat5b in signaling by IL-2 family cytokines | Q33941389 | ||
| CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites | Q33957911 | ||
| Acetylation of beta-catenin by CREB-binding protein (CBP). | Q34125251 | ||
| HATs on and beyond chromatin | Q34180684 | ||
| Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells | Q34480485 | ||
| The function of E- and Id proteins in lymphocyte development | Q34572188 | ||
| Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases | Q36278311 | ||
| Regulation of the pro-B-cell-specific enhancer of the Id1 gene involves the C/EBP family of proteins | Q36565352 | ||
| Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. | Q36674791 | ||
| RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae | Q36744711 | ||
| CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity | Q37619789 | ||
| A novel enhancer, the pro-B enhancer, regulates Id1 gene expression in progenitor B cells | Q38298152 | ||
| Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice | Q39449305 | ||
| Substitution of basic amino acids in the basic region stabilizes DNA binding by E12 homodimers | Q39716313 | ||
| Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs | Q40370630 | ||
| Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program | Q40908837 | ||
| Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3. | Q40924102 | ||
| Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. | Q41065048 | ||
| Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation | Q41140580 | ||
| The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. | Q41251712 | ||
| Acetylation of general transcription factors by histone acetyltransferases | Q41586010 | ||
| Regulation of activity of the transcription factor GATA-1 by acetylation | Q42823439 | ||
| Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3 | Q42951830 | ||
| Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow | Q44114694 | ||
| Requirement of Hos2 histone deacetylase for gene activity in yeast | Q46070318 | ||
| Id helix—loop—helix proteins in cell growth and differentiation | Q47721621 | ||
| Notch1 expression in early lymphopoiesis influences B versus T lineage determination | Q51085324 | ||
| Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. | Q52566206 | ||
| A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA | Q68033053 | ||
| Constitutive expression of the Id1 gene impairs mouse B cell development | Q71988116 | ||
| Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis | Q74171800 | ||
| Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities | Q77589702 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 893-904 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta | |
| P478 | volume | 22 |
| Q39405967 | A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer. |
| Q40425770 | A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}. |
| Q36007662 | A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli |
| Q37447875 | Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha |
| Q37081977 | Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions |
| Q89800215 | C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think! |
| Q24632924 | C/EBPβ mediates growth hormone-regulated expression of multiple target genes |
| Q58571021 | CCAAT/Enhancer Binding Protein β inhibits myogenic differentiation via ID3 |
| Q37299649 | CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter |
| Q34983912 | CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases |
| Q40318752 | Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. |
| Q36053057 | Coactivators in gene regulation by STAT5. |
| Q39613493 | Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. |
| Q34503730 | Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs. |
| Q40457847 | Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. |
| Q38354150 | Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. |
| Q84734296 | Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages |
| Q28570470 | Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent |
| Q90069087 | Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis |
| Q25257455 | Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene |
| Q35674501 | G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. |
| Q28247820 | GPR126 protein regulates developmental and pathological angiogenesis through modulation of VEGFR2 receptor signaling |
| Q47293908 | Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers. |
| Q99557261 | Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy |
| Q24297215 | Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5 |
| Q37125470 | Glucose metabolism as a target of histone deacetylase inhibitors. |
| Q34495315 | HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter |
| Q93335194 | HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies |
| Q40106493 | HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2. |
| Q42805997 | Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300. |
| Q94454420 | Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases |
| Q37070115 | Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery |
| Q45820993 | Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment |
| Q33860585 | Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas |
| Q34393807 | Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? |
| Q37621256 | Histone deacetylases and the immunological network: implications in cancer and inflammation |
| Q38240733 | Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders |
| Q42694715 | Id1 has a physiological role in regulating early B lymphopoiesis |
| Q36740156 | In vivo identification of novel STAT5 target genes |
| Q36447938 | Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. |
| Q39317669 | Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells. |
| Q28241878 | Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis |
| Q37737820 | Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion |
| Q39137648 | Interaction and Cooperation of the CCAAT-box Enhancer-binding Protein β (C/EBPβ) with the Homeodomain-interacting Protein Kinase 2 (Hipk2) |
| Q34384609 | Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. |
| Q36725004 | Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. |
| Q36157904 | Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate |
| Q33632070 | Minireview: The versatile roles of lysine deacetylases in steroid receptor signaling |
| Q37959304 | Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer |
| Q35953404 | Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system |
| Q35832501 | Multitasking of helix-loop-helix proteins in lymphopoiesis |
| Q39889099 | NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway |
| Q38500553 | Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro‐angiogenic phenotype and increased cell motility and invasiveness |
| Q38056706 | Protein complexes and target genes identification by in vivo biotinylation: the STAT5 paradigm |
| Q36402055 | Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation |
| Q24791043 | Regulation of Id2 expression by CCAAT/enhancer binding protein beta |
| Q38352015 | Regulation of elastin gene transcription by interleukin-1 beta-induced C/EBP beta isoforms |
| Q34420184 | Role of histone and transcription factor acetylation in diabetes pathogenesis |
| Q35103357 | Roles and regulation of stat family transcription factors in human breast cancer |
| Q37107328 | STAT signaling in mammary gland differentiation, cell survival and tumorigenesis |
| Q38177821 | STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis |
| Q37148066 | STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis |
| Q38140877 | STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells |
| Q47375997 | STAT5BN642H is a driver mutation for T cell neoplasia |
| Q35988744 | Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer |
| Q24298021 | Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity |
| Q34519755 | Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription |
| Q30817959 | Striking it rich by data mining |
| Q39556437 | Systematic identification of protein combinations mediating chromatin looping. |
| Q100516165 | Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming |
| Q36656068 | Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation. |
| Q92964666 | The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD |
| Q36583525 | The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition |
| Q35592108 | The role of C/EBPbeta in mammary gland development and breast cancer |
| Q37833131 | The role of STAT5 in the development, function, and transformation of B and T lymphocytes. |
| Q36425436 | The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. |
| Q51890625 | Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia |
| Q34958680 | Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) β. |
| Q40229403 | Treatment of cultured myotubes with the proteasome inhibitor beta-lactone increases the expression of the transcription factor C/EBPbeta |
| Q34113046 | Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events |
| Q34298456 | Unique suppression of prostaglandin H synthase-2 expression by inhibition of histone deacetylation, specifically in human amnion but not adjacent choriodecidua. |
| Q34587139 | Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells |
| Q39850190 | v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300. |
Search more.